Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Endocrine and Neuroendocrine Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01466036
What this trial is testing

Cabozantinib in Advanced Pancreatic Neuroendocrine and Carcinoid Tumors

Who this might be right for
Carcinoid TumorPancreatic Neuroendocrine Tumor
Dana-Farber Cancer Institute 61
Post-approval studies (Phase 4)UnknownNCT02759718
What this trial is testing

Clinical Effectiveness of Serum Chromogranin A Levels on Diagnostic of Pancreatic Neuroendocrine Tumors

Who this might be right for
Non Functioning Pancreatic Endocrine Tumor
Asan Medical Center 111
Not applicableStudy completedNCT00974610
What this trial is testing

Study of Blood Samples From Patients With Malignant Melanoma, Metastatic Breast Cancer, Advanced Lung Cancer, Pancreatic Cancer, or Colorectal Cancer.

Who this might be right for
Breast CancerColorectal CancerLung Cancer+2 more
Cancer Trials Ireland 803
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Active Not RecruitingNCT05247905
What this trial is testing

Comparing Capecitabine and Temozolomide in Combination to Lutetium Lu 177 Dotatate in Patients With Advanced Pancreatic Neuroendocrine Tumors, the ComPareNET Trial

Who this might be right for
Metastatic Pancreatic Neuroendocrine TumorUnresectable Pancreatic Neuroendocrine Carcinoma
Alliance for Clinical Trials in Oncology 31
Early research (Phase 1)UnknownNCT03934827
What this trial is testing

MRx0518 in Patients With Solid Tumours Waiting Surgical Removal of the Tumour

Who this might be right for
MelanomaBreast CancerUterine Cancer+7 more
Imperial College London 120
Not applicableLooking for participantsNCT02775461
What this trial is testing

Pancreas Registry and High Risk Registry

Who this might be right for
Pancreas CancerPancreatitisChronic Pancreatitis+3 more
Icahn School of Medicine at Mount Sinai 1,368
Not applicableLooking for participantsNCT07318051
What this trial is testing

Sample Collection for Ongoing Research and Product Evaluation Study

Who this might be right for
Breast CancerLung CancerMuscle Invasive Bladder Cancer+9 more
Natera, Inc. 9,600
Early research (Phase 1)UnknownNCT03098160
What this trial is testing

Immunotherapy Study of Evofosfamide in Combination With Ipilimumab

Who this might be right for
Pancreatic CancerMelanomaSquamous Cell Carcinoma of the Head and Neck+1 more
Threshold Pharmaceuticals 69
Testing effectiveness (Phase 2)Active Not RecruitingNCT06416085
What this trial is testing

Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer

Who this might be right for
Advanced CancerStage IV Solid Tumor CancerStage IV Sarcoma of Bone+3 more
University Health Network, Toronto 15
Not applicableStudy completedNCT00342446
What this trial is testing

A Follow-up Study of Women Evaluated and Treated for Infertility

Who this might be right for
Ovarian CancerBreast CancerEndometrial Cancer+2 more
National Cancer Institute (NCI) 12,193
Not applicableLooking for participantsNCT05645510
What this trial is testing

LIVInG With chrONic Cancer TrEatments (LONGEVITI) Study

Who this might be right for
CancerTyrosine Kinase MutationBreast Cancer+7 more
University of Alberta 75
Not applicableActive Not RecruitingNCT05037461
What this trial is testing

Precision Radiotherapy Using MR-linac for Pancreatic Neuroendocrine Tumours in MEN1 Patients

Who this might be right for
Neuroendocrine Tumor of PancreasMultiple Endocrine Neoplasia Type 1
J.M. de Laat 20
Large-scale testing (Phase 3)Study completedNCT02997553
What this trial is testing

Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery

Who this might be right for
Breast CarcinomaHead and Neck CancerMelanoma (Skin)+7 more
Institut de Cancérologie de Lorraine 744
Not applicableEnded earlyNCT03947762
What this trial is testing

Lanreotide 120mg Effectiveness in Subjects With Pancreatic Neuroendocrine Tumours (PanNET) in Routine Clinical Practice.

Who this might be right for
Pancreatic Neuroendocrine Tumor
Ipsen 54
Early research (Phase 1)Ended earlyNCT02012231
What this trial is testing

Phase I/IIa Study to Evaluate the Safety, PK, PD, and Preliminary Efficacy of PLX8394 in Patients With Advanced Cancers.

Who this might be right for
MelanomaThyroid CancerColorectal Cancer+4 more
Fore Biotherapeutics 5
Testing effectiveness (Phase 2)Active Not RecruitingNCT05199272
What this trial is testing

A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies

Who this might be right for
Solid TumorClear Cell Renal Cell CarcinomaEpithelial Ovarian Cancer+6 more
23andMe, Inc. 141
Not applicableActive Not RecruitingNCT04314401
What this trial is testing

National Cancer Institute "Cancer Moonshot Biobank"

Who this might be right for
Acute Myeloid LeukemiaAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8+26 more
National Cancer Institute (NCI) 1,600
Testing effectiveness (Phase 2)Ended earlyNCT00958841
What this trial is testing

Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin

Who this might be right for
Pancreatic NeoplasmPituitary NeoplasmNelson Syndrome+1 more
Novartis Pharmaceuticals 118
Testing effectiveness (Phase 2)Study completedNCT02643303
What this trial is testing

Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers

Who this might be right for
Head and Neck Squamous Cell CarcinomaBreast CancerSarcoma+8 more
Ludwig Institute for Cancer Research 58
Next Page